Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 4.0B | 2.3B | 6.1B | 4.5B |
Cost of revenue | 2.5B | 1.6B | 2.9B | 2.6B |
Gross profit | 1.5B | 761M | 3.2B | 1.9B |
Operating expense | ||||
Research & development | 365M | 348M | 357M | 332M |
Selling general and admin | 626M | 708M | 1.1B | 772M |
Other operating expenses | — | — | — | — |
Operating income | 327M | -465M | 1.6B | 661M |
Non operating interest income | ||||
Income | 39M | 33M | 25M | 35M |
Expense | 60M | 66M | 66M | 41M |
Other income expense | -218M | -135M | -194M | -173M |
Pretax income | 88M | -633M | 1.3B | 482M |
Tax provision | 138M | -114M | 282M | 106M |
Net income | -39M | -521M | 1.1B | 423M |
Basic EPS | -0.1 | -0.8 | 1.5 | 0.6 |
Diluted EPS | -0.1 | -0.8 | 1.5 | 0.6 |
Basic average shares | 687.3M | 691.1M | 695.9M | 700.4M |
Diluted average shares | 687.3M | 691.1M | 698.1M | 702.8M |
EBITDA | 589M | -132M | 1.9B | 960M |
Net income from continuing op. | -79M | -505M | 1.1B | 376M |
Minority interests | -2M | -3M | -3M | -4M |
Preferred stock dividends | — | — | — | — |